Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.bbcan.2010.05.002
Title: Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma
Authors: Lee, N.P.
Poon, R.T.P.
Shek, F.H.
Ng, I.O.L.
Luk, J.M. 
Keywords: Biomarker
Cadherin-17
Oncogene
Therapeutic target
Wnt signaling
Issue Date: Dec-2010
Citation: Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M. (2010-12). Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma. Biochimica et Biophysica Acta - Reviews on Cancer 1806 (2) : 138-145. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbcan.2010.05.002
Abstract: Cadherin is an important cell adhesion molecule that plays paramount roles in organ development and the maintenance of tissue integrity. Dysregulation of cadherin expression is often associated with disease pathology including tissue dysplasia, tumor formation, and metastasis. Cadherin-17 (CDH17), belonging to a subclass of 7D-cadherin superfamily, is present in fetal liver and gastrointestinal tract during embryogenesis, but the gene becomes silenced in healthy adult liver and stomach tissues. It functions as a peptide transporter and a cell adhesion molecule to maintain tissue integrity in epithelia. However, recent findings from our group and others have reported aberrant expression of CDH17 in major gastrointestinal malignancies including hepatocellular carcinoma (HCC), stomach and colorectal cancers, and its clinical association with tumor metastasis and advanced tumor stages. Furthermore, alternative splice isoforms and genetic polymorphisms of CDH17 gene have been identified in HCC and linked to an increased risk of HCC. CDH17 is an attractive target for HCC therapy. Targeting CDH17 in HCC can inhibit tumor growth and inactivate Wnt signaling pathway in concomitance with activation of tumor suppressor genes. Further investigation on CDH17-mediated oncogenic signaling and cognate molecular mechanisms would shed light on new targeting therapy on HCC and potentially other gastrointestinal malignancies. © 2010 Elsevier B.V.
Source Title: Biochimica et Biophysica Acta - Reviews on Cancer
URI: http://scholarbank.nus.edu.sg/handle/10635/125894
ISSN: 0304419X
DOI: 10.1016/j.bbcan.2010.05.002
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

42
checked on Oct 21, 2020

WEB OF SCIENCETM
Citations

39
checked on Oct 21, 2020

Page view(s)

60
checked on Oct 17, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.